Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis

NCT04707703 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Participant enrollment challenges

Conditions

Severe Acute Respiratory Syndrome Coronavirus 2
Aspergillosis Invasive

Interventions

DRUG: Isavuconazonium Injection [Cresemba]
DRUG: Placebo

Sponsor

Jeffrey Jenks, MD, MPH

Collaborators

[object Object]